Demetra, an independent international medical company providing bone cements, spacers and biomaterials for orthopaedic applications and orthopaedic infection control, has announced a strategic asset purchase from Next Science, an Australia-based ASX-listed…
Australia: Demetra adds to portfolio of infection management solutions with Next Science asset purchase
…
…






